Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001884|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : July 2, 2017
Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown.
Researchers hope to improve their understanding of the disease process involved in PF and RA by analyzing specimens collected by bronchoscopy, lung biopsy, lung transplantation, or autopsy from patients with these conditions.
The purpose of this study is to collect specimens from rheumatoid arthritis patients with and without pulmonary fibrosis as well as patients with pulmonary fibrosis without associated diseases or cause (idiopathic pulmonary fibrosis).
|Condition or disease|
|Pulmonary Fibrosis Rheumatoid Arthritis|
|Study Type :||Observational|
|Official Title:||Specimen Procurement for Individuals With Pulmonary Fibrosis Associated With Rheumatoid Arthritis|
|Study Start Date :||March 21, 1999|
|Estimated Study Completion Date :||December 28, 2007|
U.S. FDA Resources
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001884
|United States, Massachusetts|
|Boston, Massachusetts, United States, 02118-2354|